FDA approves experimental drug for depression

By  | 

LANSING, Mich. (WILX) There may soon be a new drug available for those battling depression.

An FDA advisory panel approved an experimental drug from Johnson & Johnson Tuesday. The nasal spray will be for patients who have not benefitted from other antidepressants.

Drugs in the spray have been shown in previous studies to help people with severe depression.

The FDA is expected to announce its decision on the drug by March 4th.